Is It OK to Take Supplements After a Prostate Cancer Diagnosis?

Is It OK to Take Supplements After a Prostate Cancer Diagnosis?

by | Dec 28, 2025 | Cancer Resources, Health Resources, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, mHSPC, Nutrition, Prostate Cancer, Recent News

Is It OK to Take Supplements After a Prostate Cancer Diagnosis?  by Stuart Jordan

We were recently asked by a newly diagnosed member of our group—who is preparing to begin treatment—about a dietary supplement he has been taking. His question had two parts: Could this supplement help with prostate cancer? And just as important, is it safe to keep taking it now?

It’s a fair question, and a very common one. Many supplements are marketed as supportive of prostate health, metabolism, or weight management, and it’s easy to assume they might be helpful during cancer treatment.

In my day job as publisher of the Wellness Letter, we often see how supplement claims outpace the science behind them. That’s why we rely on evidence-based research as the final word when exploring questions like these.

When we look closely at the research, the picture is clearer than the marketing suggests. So far, no dietary supplement has been shown in solid human studies to prevent, treat, or slow the progression of prostate cancer once diagnosed. Some supplements that once sounded promising haven’t held up in careful trials. Others affect lab markers, such as PSA, without improving outcomes that truly matter. In fact, some supplements—like high-dose vitamin E or selenium—have actually shown potential harm in trials.

Safety is just as important. Supplements and over-the-counter products can interact with medications, affect lab results, or interfere with how treatments work. This matters whether a man is on active surveillance, receiving hormone therapy, undergoing radiation therapy, or after treatment. Even products that seem harmless can complicate care if the medical team isn’t aware of them.

That’s why it’s essential to tell your doctors about every supplement and over-the-counter product you’re taking, not just prescriptions.

Instead of relying on supplements, focusing on overall health—through diet, physical activity, weight management, and addressing true deficiencies—offers a safer, better-supported path, especially when coordinated closely with your medical team.

-Stuart Jordan 

Article Review – A Clear Guide to PCa Biomarkers

Article Review – A Clear Guide to PCa Biomarkers

by | Dec 24, 2025 | Active Surveillance PCa, Cancer Resources, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, Prostate Cancer

Article Review – A Clear Guide to PCa Biomarkers

DISCLAIMER: AnCan does not endorse Superpower or any of its products.  All patients should discuss with their healthcare provider before using any of their products or any of the tests or advice in the article.

In another of the seemingly endless organizations offering premium health services, Superpower, founded in 2023, provides a fairly straightforward overview of the myriad tests and biomarkers available to Prostate Cancer patients (A Clear Guide to PCa Biomarkers).  Seasoned AnCaners may find little new in here, especially those that attend or review many of the recent seminars/webcasts, but newcomers or those needing a refresher may find it helpful for further research or equipping you to be your own best advocate. The article hits many of the main tests with which we are all familiar, as well as some of the urine biomarkers (PCA3, Select MDx, ExoDX), without specifically endorsing any of them.  It does touch on MRIs, but only multi-parametric, not bi-parametric MRIs, nor does it get into the trans-rectal versus trans-perineal debate. Be forewarned, there is information with which not everyone will agree (shocking, I know), but it is still a useful, albeit somewhat rudimentary tool.

🌿 FDA Position on Cannabis and Cannabinoids

🌿 FDA Position on Cannabis and Cannabinoids

by | Dec 19, 2025 | Blood Cancers, Brain Tumors, Cancer Caregivers, Cancer Resources, Complementary Medicine, High Risk/Recurrent/Advanced, High Risk/Recurrent/Advanced Prostate Cancer, hospice and palliative, Low/Intermediate Prostate Cancer, mCRPC, Mental Health, mHSPC, Multiple Sclerosis, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Recent News, RMC, Thyroid Cancer, Uncategorized

🌿 FDA Position on Cannabis and Cannabinoids

(Here is my take on this article Therapeutic Use of Cannabis and Cannabinoids A Review JAMA Network, 11/26/25.  On a personal side, I use CBD to help me sleep, and with a little (5%) addition of THC, it is a great anxiety calmer – Sally Torgeson, AnCan Blood Cancer Moderator & Multiple Myeloma Coach)

Unapproved Cannabis

  • The FDA has NOT approved the cannabis plant (botanical marijuana) for any medical use or indication.
  • Because it is classified as a Schedule I controlled substance under federal law, the FDA has not found it to be safe or effective for the treatment of any disease or condition [1.1, 1.7].
  • It is currently illegal to market CBD by adding it to food or labeling it as a dietary supplement in interstate commerce [2.1, 2.5].

FDA-Approved Cannabinoid Drugs

The FDA has approved a small number of prescription drugs containing either a purified cannabis-derived compound or synthetic cannabinoids:

  • Epidiolex (Cannabidiol or CBD): The only FDA-approved drug that contains a purified substance derived directly from the cannabis plant. It is approved to treat seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients one year of age and older [1.8, 2.1].
  • Marinol and Syndros (Dronabinol): Contain synthetic Δ9-tetrahydrocannabinol (THC). Approved for:
    • Nausea and vomiting associated with cancer chemotherapy in patients who have not responded to conventional antiemetic treatments [2.2, 2.3].
    • Anorexia associated with weight loss in patients with HIV/AIDS [2.3].
  • Cesamet (Nabilone): Contains a synthetic substance that is chemically similar to THC. Approved for chemotherapy-induced nausea and vomiting [1.1, 2.3].

Regulatory Context

  • The FDA maintains its authority to regulate products containing cannabis or cannabis-derived compounds, even those derived from hemp (cannabis with less than 0.3% THC), under the Federal Food, Drug, and Cosmetic (FD&C) Act [1.4].
  • The FDA supports the development of new drugs through proper clinical trials to ensure they meet standards for safety and effectiveness [1.1, 2.4].

FDA-Approved Cannabinoid Drugs and Their Conditions

Drug Name (Active Ingredient) Source FDA-Approved Condition(s)
Epidiolex (Cannabidiol or CBD) Purified, plant-derived CBD Seizures associated with: * Lennox-Gastaut syndrome (LGS) * Dravet syndrome (DS) * Tuberous Sclerosis Complex (TSC)
Marinol and Syndros (Dronabinol) Synthetic THC ($ \Delta9 $-tetrahydrocannabinol) * Nausea and vomiting caused by cancer chemotherapy (when other antiemetics have failed) * Anorexia (loss of appetite) associated with weight loss in patients with HIV/AIDS
Cesamet (Nabilone) Synthetic cannabinoid (similar to THC) * Nausea and vomiting caused by cancer chemotherapy (when other antiemetics have failed)

Key Takeaway

  • Epidiolex is the only drug approved that contains a substance derived directly from the Cannabis plant (CBD). It represents the strongest evidence for cannabinoid efficacy in reducing seizure frequency in certain rare forms of epilepsy [1.1, 1.2].
  • The synthetic THC compounds (Dronabinol and Nabilone) are used primarily as a last resort for severe nausea/vomiting related to chemotherapy and for appetite stimulation in AIDS patients [1.2, 2.8].

The FDA has not approved the use of the whole cannabis plant for any medical condition, stressing the importance of standardized, tested pharmaceuticals for patient safety and proven effectiveness [1.7].1

 

🏷️ Off-Label Use vs. Unapproved Use

1. Off-Label Use (Legal and Regulated)

 

This applies only to drugs that the FDA has already approved.

  • What it is: Using an FDA-approved drug (like Epidiolex, Marinol, or Cesamet) for a condition, dose, or patient population that is not specifically listed on the drug’s official label.   
  • Legality: It is legal for a licensed physician to prescribe an approved drug for an off-label use if they believe it is medically appropriate for their patient.
  • FDA Position: The FDA does not regulate the practice of medicine; however, the manufacturer cannot market or promote the drug for the off-label use. The safety and efficacy for the off-label use have not been verified by the FDA’s rigorous testing process.

Example: A doctor prescribing Marinol (Dronabinol), which is approved for nausea from chemotherapy, to a patient for chronic pain. The drug is approved, but the condition (chronic pain) is not on the label.

2. Unapproved Use (Non-FDA Approved Products)

This applies to the cannabis plant itself and most CBD/cannabinoid products on the market.

  • What it is: Using the whole cannabis plant (botanical marijuana) or non-FDA-approved cannabis-derived products (like most CBD oils, edibles, or topicals) for any medical purpose.
  • Legality:
    • Federal: The whole plant is a Schedule I controlled substance and is not federally approved for any medical use.   
    • State: Use may be legal under state medical or recreational cannabis laws, but this does not change its status as an unapproved drug under federal FDA law.
  • FDA Position: The FDA considers these products unapproved drugs and/or illegally marketed products (especially when CBD is added to food or marketed as a dietary supplement), as they have not been tested for safety, effectiveness, or quality assurance.   

Example: A patient using a CBD tincture (which is not Epidiolex) to treat anxiety, or using THC flower to help with multiple sclerosis symptoms.

To correspond with Sally, please send an email to info@ancan.org, and we’ll be sure to send along.

Low/Intermediate PCa Video Chat, December 8, 2025

Low/Intermediate PCa Video Chat, December 8, 2025

by | Dec 12, 2025 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, December 8, 2025

Low/Intermediate PCa Video Chat, December 8, 2025

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Focal therapy sounds great but has higher risk of recurrence. (bj)

Topics Discussed
Importance of getting a second opinion on your biopsy slides by a specialist; don’t rush into a treatment without getting all the information; focal therapy sounds great but has higher risk of recurrence; active surveillance is a viable treatment option—it depends on your risk factors; cryotherapy vs HIFU—effectiveness vs side-effects; fears about erectile dysfunction (ED) and incontinence make focal therapy make it easy to jump on the focal therapy bandwagon; heart disease and hormone therapy (ADT) interactions; balancing open-heart surgery and managing prostate cancer (PCa); symptom management concerns cause me to lean toward IMRT (Intensity-Modulated Radiation Therapy) vs SBRT (Stereotactic Body Radiation Therapy); concerns about ADT side effects.

Chat

AnCan – Stuart sent a chat · 7:56 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

AnCan – Stuart sent a chat · 7:56 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

AnCan Bill  sent a chat · 8:17 PM
If you are new, feel free to share your email address here and we will ensure you get our reminders.

AnCan Bill  sent a chat · 8:32 PM
Steve, we were getting a lot of mic noise from you.  We muted you.

Larry (Veteran, Alaskan) sent a chat · 8:33 PM
Do not overlook the potential value of getting a consult from a Medical Oncologist as opposed to Surgical or Radiological.

Martin  Uthe sent a chat · 8:35 PM
Stuart, What is your email? Thank you.

Martin  Uthe sent a chat · 8:36 PM
Larry, Thank you. M

AnCan – rick sent a chat · 8:36 PM
stuart@ancan.org

AnCan – rick sent a chat · 8:40 PM
I would disagrree with Larry at this time. With just a mm or two of 4+3 that we are checking with a 2nd opinion, most Genitourinary medical oncologists would not see you. You will not be able to get an appointment with Maha Hussein or David VanderWeele.   Just seeing a general med onc will only confuse you.

Martin  Uthe sent a chat · 8:41 PM
I am already confused!

Tom O NJ sent a chat · 8:44 PM
Martin confusion is why this group exist… keep coming keep doing research. I am new also and struggling w/ decision making.

Martin  Uthe sent a chat · 8:45 PM
Thank you, Tom.

AnCan Bill  sent a chat · 8:47 PM
Thanks Tom. We are here to help as best we can.

AnCan – Boykin sent a chat · 9:02 PM
Active Surveillance https://ancan.org/event/active-surveillance-prostate-cancer-2/2025-12-10/

Steve sent a chat · 9:10 PM
I was wondering if I should push for a Decipher test now?

Steve sent a chat · 9:11 PM
I tried to get one but its a bit hard from a foriegn country without a US Dr.

AnCan – rick sent a chat · 9:12 PM
Speak with Epstein first and also ask him.  May help but I don’t know enough about Decipher. Dr. John does.

AnCan – rick sent a chat · 9:13 PM
We’re awae that it’s hard to get Decipher outside the country.

Steve sent a chat · 9:13 PM
ok 👍

Steve sent a chat · 9:13 PM
Yes I had Invitae genetic test … all negative.

Steve sent a chat · 9:14 PM
12 genes tested

AnCan – rick sent a chat · 9:14 PM
From Dr. John …. Steve: since there is some ambiguity, why not, if Epstein agrees

AnCan – rick sent a chat · 9:15 PM
Invitae is a germline test – very different to Decipher.

Steve sent a chat · 9:16 PM
Yep understand re: germline … I might have used wrong terminology

Steve sent a chat · 9:16 PM
Thanks Rick

Steve sent a chat · 9:17 PM
Any thoughts on state of the air radiation treatments if I end up there?

AnCan Bill  sent a chat · 9:18 PM
bfranklin@ancan.org

Steve sent a chat · 9:19 PM
My connection dropped so not sure if I missed any texts

Steve sent a chat · 9:19 PM
re: Radiation.

AnCan – rick sent a chat · 9:20 PM
My bad…. didn’t realize the mic was on.

AnCan–John A sent a chat · 9:21 PM
Steve: likely SBRT

Steve sent a chat · 9:21 PM
ok, does that imply MRI Guided?

AnCan–John A sent a chat · 9:23 PM
Steve: probably at a state of the art center.    Maybe CT

Steve sent a chat · 9:23 PM
CT?

AnCan–John A sent a chat · 9:23 PM
Computerized Axial Tomography

Steve sent a chat · 9:24 PM
Got ya, thanks 🙂

Steve sent a chat · 9:25 PM
SBRT with Real-Time Tracking (CyberKnife)?

AnCan–John A sent a chat · 9:26 PM
that’s an example yes

Steve sent a chat · 9:26 PM
MRI-Guided SBRT (MR-Linac: ViewRay MRIdian or Elekta Unity)

AnCan Bill  sent a chat · 9:27 PM
Dr. Sanoj Punnen

Steve sent a chat · 9:27 PM
I will also check with my oncologist who I am seeing for Pet scan in a few hours

AnCan Bill  sent a chat · 9:30 PM
https://sylvester-doctors.umiamihealth.org/

AnCan – rick sent a chat · 9:32 PM
https://sylvester-doctors.umiamihealth.org/

Steve sent a chat · 9:32 PM
I’m considering adding Dr. Kishan at UCLA to my trip.

Steve sent a chat · 9:36 PM
Did you have side effects?

Steve sent a chat · 9:37 PM
I like the idea he is on west coast as its already about 20-25 hrs flight time to get to CA 🙂

AnCan – rick sent a chat · 9:45 PM
dr.john@ancan.org

AnCan – rick sent a chat · 9:46 PM
https://www.uwmedicine.org/bios/effie-andrikopoulou

Steve sent a chat · 9:50 PM
Who was the Dr at UCSF who I should talk to re: Active Surveillance?

AnCan – rick sent a chat · 9:53 PM
UCSF – Peter Carrroll is the expert but winding down. Matt Cooperberg is one. If you can’t get to him, Sam Washington.

Steve sent a chat · 9:54 PM
Thanks Rick 👍

Steve sent a chat · 9:55 PM
Did you have the name and contact of the guy in Malaysia (I think it was you who mentioned him).

AnCan – rick sent a chat · 9:57 PM
Read this metastudy …. https://jamanetwork.com/journals/jamaoncology/article-abstract/2841671?guestAccessKey=d03b0908-90c8-497e-85cd-aebb43ec2a63&utm_medium=email&utm_source=postup_jn&utm_campaign=article_alert-jamaoncology&utm_content=olf-tfl_&utm_term=112025&mc_cid=0fa42784f6&mc_eid=838454d636

Steve sent a chat · 10:01 PM
Thanks so much for all the help guys.  Makes my path alot more focused on best next steps.  Much appreciated 🙏

Steve sent a chat · 10:05 PM
My connection dropped again… back on now

AnCan Bill  sent a chat · 10:05 PM
We are glad you found us. Please keep coming to the group.

Steve sent a chat · 10:06 PM
You guys give us alot more confidence dealing with PC

Steve sent a chat · 10:10 PM
Rick/Stuart do you guys mind sharing your email?

AnCan Bill  sent a chat · 10:11 PM
rd@ancan.org and stuart@ancan.org

AnCan – Stuart sent a chat · 10:11 PM
https://www.uclahealth.org/providers/amar-kishan

AnCan – Stuart sent a chat · 10:12 PM
MR-Linac

Paul N. sent a chat · 10:14 PM
Ask Keeshan about the Prostox test

AnCan Bill  sent a chat · 10:20 PM

Special Presentation: What if You Could Predict the Risk of Radiation Effects – Prostox and Beyond

Carl S. sent a chat · 10:21 PM
Thanks guys, see you next time.

Manuel sent a chat · 10:21 PM
Thanks for a great session!

Steve sent a chat · 10:22 PM
Thanks Guys 🙂

Special Presentation: What if You Could Predict the Risk of Radiation Effects – Prostox and Beyond

by | Dec 11, 2025 | High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, Webinars

Special Presentation: What if You Could Predict the Risk of Radiation Effects – Prostox and Beyond

 

 

Featuring Dr. Joanne Weidhaas, developer of the Prostox test. Dr. Weidhaas is a radiation oncologist/ professor at UCLA. Co-discoverer of the biomarker KRAS-variant, she co-founded MiraDx, maker of Prostox, and MiraKind to empower individuals with meaningful health information. Dr. Weidhass’ professional and academic resume includes MSKCC, Yale and Stanford, largely in breast cancer. She also finds time to care for 3 kids and save dogs!

Learn more about Prostox here: https://miradx.com/prostox/

 

 

Low/Intermediate PCa Video Chat, December 8, 2025

Low/Intermediate PCa Video Chat, November 24, 2025

by | Nov 26, 2025 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, November 24, 2025

Low/Intermediate PCa Video Chat, November 24, 2025

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Manage “buyer’s remorse” by trusting the decision. (bj)

Topics Discussed
Before treatment (cryotherapy/radiation), get a second pathology opinion (e.g., Dr. Epstein/Dr. Zhou) to confirm Gleason scores; high Decipher scores (e.g., 87) with favorable pathology (Gleason 3+4) may not necessitate leaving Active Surveillance; consult Centers of Excellence. Verify facility accreditation (NCI/NCCN “Centers of Excellence”); manage “buyer’s remorse” by trusting the decision (e.g., MRI-guided SBRT over surgery); weigh recurrence risks of focal versus whole-gland treatment; assess if a PSMA PET scan is necessary for localized intermediate-risk disease; review data on Androgen Deprivation Therapy (ADT) with radiation; consider short-term ADT (6 months) only for multiple intermediate risk factors; consider radiation (SBRT) with whole pelvic coverage over surgery for suspected extra-prostatic disease (lymph nodes) to avoid salvage radiation; use a low Decipher score (e.g., 0.26) to support foregoing ADT with radiation for intermediate-risk cancer.

Chat

AnCan – Stuart sent a chat · 7:58 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

AnCan – Stuart sent a chat · 7:59 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

AnCan–John A sent a chat · 8:41 PM
I am grateful to Howie for the term “sixes over sevens”.   I am going to create a new Gleason system using poker terms.

AnCan Bill  sent a chat · 8:42 PM
Well, I wouldn’t want a full house!

AnCan – rick sent a chat · 8:44 PM
McClure at Weill

AnCan – rick sent a chat · 8:46 PM
Vince Laudone and James Eastham at MSKCC

AnCan–John A sent a chat · 8:47 PM
Howie if you want I’ll read your complete Decipher report including GRID report

Mark Erickson sent a chat · 8:57 PM
can you please repeat how to tell if a group is a center of excellence

Larry (Alaska) sent a chat · 8:59 PM
There are 33 NCCN “Centers of Excellence” scattered across the country.

Larry (Alaska) sent a chat · 8:59 PM
https://www.nccn.org/home/member-institutions

AnCan–John A sent a chat · 8:59 PM
The accrediting groups are the NCCN National Comprehensive Cancer Network, or NCI National Cancer Institute.  Go to the website and navigate to Centers of Excellence

AnCan–John A sent a chat · 9:00 PM
thx Larry

AnCan – rick sent a chat · 9:00 PM
877 582 7011

David in Portland, OR sent a chat · 9:01 PM
One picture=1,000 words. This map shows the location of all the NCCN member institutions: https://www.nccn.org/home/member-institutions/

AnCan – rick sent a chat · 9:02 PM
NCI Centers link http://www.cancer.gov/research/nci-role/cancer-centers/find

AnCan Bill  sent a chat · 9:02 PM
Thank you Larry

Mark Erickson sent a chat · 9:02 PM
Thanks all

Larry (Alaska) sent a chat · 9:10 PM
I am a master or buyer’s remorse, seller’s remorse, second guessing and hindsight.  But one makes a decision based on the best information you have and do not hesitate, dither or delay.

Ancan – Boykin sent a chat · 9:13 PM
Recognize that any treatment has consequences. Decide what you can live with. In the end, it’s a personal decision

Jim Stewart Reno, NV sent a chat · 9:22 PM
Have to sign off, Happy Thanksgiving everyone!!!!

Ancan – Boykin sent a chat · 9:23 PM
Happy Thanksgiving Jim!

AnCan Bill  sent a chat · 9:23 PM
Take care Jim.

Bill (VA) sent a chat · 9:30 PM
First meeting I have understood what the focal/nano knife concern is on recurrence.

AnCan – rick sent a chat · 9:34 PM
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer. https://ancan.us14.list-manage.com/track/click?u=ece3f3da90f82cb974b407396&id=06c8899f70&e=838454d636

AnCan – rick sent a chat · 9:35 PM
JAMA https://jamanetwork.com/journals/jamaoncology/fullarticle/2841671?guestAccessKey=d03b0908-90c8-497e-85cd-aebb43ec2a63&utm_medium=email&utm_source=postup_jn&utm_campaign=article_alert-jamaoncology&utm_content=olf-tfl_&utm_term=112025&mc_cid=0fa42784f6&mc_eid=838454d636

Mark Erickson sent a chat · 9:39 PM
Thanks everyone, Happy Thanksgiving

Ancan – Boykin sent a chat · 9:39 PM
Good Night Mark!

Larry (Alaska) sent a chat · 9:41 PM
Marc, it is a choice (in my mind) between 1) hit it hard and fast with risk of side effects or hit it minimally with s higher risk of recurrence

AnCan–John A sent a chat · 9:41 PM
‘night guys

David in Portland, OR sent a chat · 9:41 PM
Trip Trial compared six months to 30 months of ADT in randomized high risk patients who underwent beam plus brachy. It found no difference in outcomes. The incidence of biochemical recurrence rate at 7 years was 9%: https://www.redjournal.org/article/S0360-3016(23)07843-4/abstract

Bruce Schrimpf sent a chat · 9:56 PM
Great seeing and hearing from all of you!  I plan on being with the high-risk group tomorrow.  I will have an update tomorrow as I have recently returned from Mayo at Rochester.

Ancan – Boykin sent a chat · 9:57 PM
Good night Bruce!

AnCan – Stuart sent a chat · 10:05 PM
https://www.mskcc.org/nomograms/prostate

Tom O NJ sent a chat · 10:11 PM
Happy Thanksgiving All !!